Prostate carcinogenesis and inflammation: emerging insights
- PMID: 15498784
- DOI: 10.1093/carcin/bgh317
Prostate carcinogenesis and inflammation: emerging insights
Abstract
Prostate cancer remains a significant health concern for men throughout the world. Recently, there has developed an expanding multidisciplinary body of literature suggesting a link between chronic inflammation and prostate cancer. In support of this hypothesis, population studies have found an increased relative risk of prostate cancer in men with a prior history of certain sexually transmitted infections or prostatitis. Furthermore, genetic epidemiological data have implicated germline variants of several genes associated with the immunological aspects of inflammation in modulating prostate cancer risk. The molecular pathogenesis of prostate cancer has been characterized by somatic alterations of genes involved in defenses against inflammatory damage and in tissue recovery. A novel putative prostate cancer precursor lesion, proliferative inflammatory atrophy, which shares some molecular traits with prostate intraepithelial neoplasia and prostate cancer, has been characterized. Here, we review the evidence associating chronic inflammation and prostate cancer and consider a number of animal models of prostate inflammation that should allow the elucidation of the mechanisms by which prostatic inflammation could lead to the initiation and progression of prostate cancer. These emerging insights into chronic inflammation in the etiology of prostate carcinogenesis hold the promise of spawning new diagnostic and therapeutic modalities for men with prostate cancer.
Similar articles
-
Inflammation and prostate cancer.Can J Urol. 2006 Feb;13 Suppl 1:46-7. Can J Urol. 2006. PMID: 16526982
-
Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.J Urol. 2006 Sep;176(3):1108-13. doi: 10.1016/j.juro.2006.04.075. J Urol. 2006. PMID: 16890703
-
Inflammation, atrophy, and prostate carcinogenesis.Urol Oncol. 2007 Sep-Oct;25(5):398-400. doi: 10.1016/j.urolonc.2007.05.007. Urol Oncol. 2007. PMID: 17826659 Review.
-
Prostate cancer prevention.Curr Opin Urol. 2007 May;17(3):157-67. doi: 10.1097/MOU.0b013e3280eb110f. Curr Opin Urol. 2007. PMID: 17414513 Review.
-
The role of inflammation and infection in the pathogenesis of prostate carcinoma.BJU Int. 2007 Oct;100(4):733-7. doi: 10.1111/j.1464-410X.2007.07091.x. Epub 2007 Jul 23. BJU Int. 2007. PMID: 17662075 Review.
Cited by
-
Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines.EMBO Mol Med. 2012 Aug;4(8):791-807. doi: 10.1002/emmm.201101140. Epub 2012 Jun 29. EMBO Mol Med. 2012. PMID: 22745041 Free PMC article.
-
A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago.Infect Agent Cancer. 2011 Dec 7;6:25. doi: 10.1186/1750-9378-6-25. Infect Agent Cancer. 2011. PMID: 22151996 Free PMC article.
-
Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia.Arch Med Sci. 2015 Apr 25;11(2):385-94. doi: 10.5114/aoms.2015.50970. Epub 2015 Apr 23. Arch Med Sci. 2015. PMID: 25995756 Free PMC article.
-
Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis.Can Urol Assoc J. 2009 Aug;3(4):323-330. doi: 10.5489/cuaj.1129. Can Urol Assoc J. 2009. PMID: 19672448 Free PMC article.
-
Prostate calculi in cancer and BPH in a cohort of Korean men: Presence of calculi did not correlate with cancer risk.Asian J Androl. 2010 Mar;12(2):215-20. doi: 10.1038/aja.2009.86. Epub 2009 Dec 28. Asian J Androl. 2010. PMID: 20037598 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical